| T2 Biosystems, Inc. |
10%+ Owner |
Common Stock |
4.7M |
$741K |
$0.16 |
May 9, 2024 |
By CRG Partners III - Parallel Fund B (Cayman) L.P. |
| T2 Biosystems, Inc. |
10%+ Owner |
Series B Convertible Preferred Stock |
59.7K |
|
|
Jul 3, 2023 |
By CRG Partners III Parallel Fund (B) (Cayman) L.P. |
| T2 Biosystems, Inc. |
10%+ Owner |
Series B Convertible Preferred Stock |
33.6K |
|
|
Jul 3, 2023 |
By CRG Partners III (Cayman) Lev AIV I L.P. |
| T2 Biosystems, Inc. |
10%+ Owner |
Series A Convertible Preferred Stock |
28K |
|
|
Apr 12, 2024 |
By CRG Partners III - Parallel Fund B (Cayman) L.P. |
| Avinger Inc |
10%+ Owner |
Series E Convertible Preferred Stock |
733 |
|
|
Aug 4, 2023 |
By CRG Partners III Parallel Fund (B) (Cayman) L.P. |
| Avinger Inc |
10%+ Owner |
Series E Convertible Preferred Stock |
658 |
|
|
Aug 4, 2023 |
By CRG Partners III (Cayman) Lev AIV I L.P. |
| Avinger Inc |
10%+ Owner |
Series E Convertible Preferred Stock |
310 |
|
|
Aug 4, 2023 |
By CRG Partners III L.P. |
| Avinger Inc |
10%+ Owner |
Series E Convertible Preferred Stock |
166 |
|
|
Aug 4, 2023 |
By CRG Partners III ? Parallel Fund (A) L.P. |
| Avinger Inc |
10%+ Owner |
Series E Convertible Preferred Stock |
53.4 |
|
|
Aug 4, 2023 |
By CRG Partners III (Cayman) Unlev AIV I L.P. |
| T2 Biosystems, Inc. |
10%+ Owner |
Series A Preferred Stock |
0 |
|
|
May 9, 2024 |
By CRG Partners III - Parallel Fund B (Cayman) L.P. |
| T2 Biosystems, Inc. |
10%+ Owner |
Series B Preferred Stock |
0 |
|
|
May 9, 2024 |
By CRG Partners III - Parallel Fund B (Cayman) L.P. |